$TENX Reports Positive Results from Phase 2 Trial of Levosimendan in Patients with Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction.  

#stocks #stockstowatch #StockTrading #StocksToTrade #stockMarket 

super #Lowfloat #lowfloater